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CHAPTER 1. GENERAL.INTRODUCTION 
Introduction 
Lentiviruses, a subfamily of retroviruses, are a group of exogenous, 
nononcogenic viruses that cause chronic and variable clinical disease syndromes 
such as fever, anemia, central nervous system disorders, pneumonia, 
lymphadenopathy and immunodeficiency. This group of viruses includes human 
immunodeficiency virus (HIV), simian immunodeficiency virus (SIV), equine 
infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), bovine 
immunodeficiency virus (BIV) and jembrana disease virus (JDV) 
(4, 18,23,33,39,49,53,69). 
BIV occurs worldwide and is associated with chronic immune and central 
nervous system lesions. R29, the original BIV, was isolated in Louisiana in 1969 
from the leukocytes of a cow with persistent lymphocytosis, lymphadenopathy and 
lesions in the central nervous system (79). Two functional proviruses, R29-127 and 
R29-106, were sequenced and analyzed and shown to be genetically and 
antigentically related to HIV (34,39). In vivo studies of R-29 identified no overt 
clinical signs following experimental infection. Transient clinical signs, such as 
pyrexia, neutropenia and lymphocytosis, were observed (29,48,62). In 1993, the 
Florida strain of BIV was isolated from a seropositive dairy herd in Florida (76). In 
vitro, FL 112 had a longer incubation time between passages and a slower lysis of 
infected cells. FL 112-infected cattle had a greater increase in the number of 
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mononuclear cells and more pronounced histopathological lesions compared to 
the R-29 -infected cattle (76). Though there are some differences between the two 
strains, there are no reports of acute fatal disease caused by BIV in naturally or 
experimentally infected cattle. In general, BIV was found to be a mildly pathogenic 
bovine lentivirus. 
Jembrana disease virus (JDV), the other species of bovine lentivirus, shows 
differences in in vivo levels of replication and pathogenicity from BIV (74). JDV is 
only found in some species of cattle in Indonesia, primarily in Bali cattle, and does 
not cause infection worldwide. After 5 to 12 days of infection, viral titers can reach 
108 units per ml. JDV replicates very fast and causes an acute, fatal disease in 
infected animals (74). The major clinical signs associated with JDV-infected cattle 
are fever, lethargy, anorexia and enlargement of the superficial lymph nodes. The 
mortality rate of experimentally infected cattle is reported to be 17% (74). Though 
BIV and JDV are both bovine lentiviruses, the different pathogenicities lead us to 
wonder what are the important factor(s) that contribute to viral pathogenesis. One 
notable difference between JDV and BIV is the level of virus replication in vivo. 
Therefore, factors which control virus replication may contribute to differences in 
viral pathogenicity. 
Lentiviruses have a complex genome structure. The long terminal repeats 
(L TR) flank the structural genes gag-pol-env. The L TR is the only promoter in the 
lentivirus genome and is divided into three regions, U3, Rand US (19,24,77). In 
the U3 region, there are many cis-acting sites which function as transcriptional 
enhancers during virus replication (10, 19,24,31,77). Transcription starts at the U3 
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and R border. The R region contains transactivation response region (TAR). Tat, 
the virus encoded protein, specifically binds to the secondary loop-stem structure 
TAR structure, and increases the initiation and elongation of viral transcription 
(10,31,43,80). Therefore, both viral and cellular proteins contribute to L TR 
promoter activity. Because the L TR is the only promoter and is an important 
regulator in viral transcription and replication, the L TR becomes a critical factor in 
studies of viral pathogenesis. 
Sequence comparison between BIV and JDV L TRs showed that the JDV 
L TR was very divergent. The nucleotide substitutions were dispersed throughout 
the whole LTR sequence and, except for the common TATA box, there appeared to 
be few common transcription factor binding sites between BIV and JDV (12,35). 
Also, the JDV U3 region contained a 192 nucleotide(nt) deletion as compared to 
BIV. Due to many nucleotide substitutions in the R region, the predicted TAR 
secondary structure of JDV was different from BIV TAR (12). The sequence 
information, and the knowledge about pathogenesis and viral replication, led to our 
hypothesis that the L TR sequence heterogeneity between BIV and JDV 
differentially regulates the basal and/or Tat-mediated transcription and contributes 
to the difference in viral replication and pathogenesis. To test the hypothesis, there 
were three specific aims in the project. 
Specific Aims 
1. Compare the L TR nucleotide sequences of the three bovine lentivirus, R-29, 
FL 112 and JDV. 
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2. Determine if the L TRs of R-29, FL 112 and JDV exhibit different levels of basal/or 
Tat-mediated transcription. 
3. Determine if the different transcription levels among R-29, FL 112 and JDV map 
to the U3 and/or R-U5 region of the L TR. 
Thesis Organization 
This thesis consists of a manuscript which is preceded by General 
Introduction and Literature Review sections and followed by General Conclusion 
and Literature Cited sections. The format of the manuscript is that of the journal to 
which it is to submitted. Bibliographical information corresponding to citations in 
the whole thesis is located in the Literature Cited section. 
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CHAPTER 2. LITERATURE REVIEW 
Pathogenesis of Bovine Lentiviruses 
Lentiviruses are a widely disseminated group of exogenous, nononcogenic 
retroviruses. The lentiviruses are associated with lifelong, persistent infection and 
a chronic, variable disease course (40). Few groups of viruses get as much 
attention as retroviruses because of their importance as human and animal 
pathogens and also because of their remarkable value as experimental systems. 
Many lentiviruses have been identified, including human immunodeficiency virus 
(HIV), simian immunodefiency virus (SIV), equine infectious anemia virus (EIAV), 
feline immunodeficiency virus (FIV), bovine immunodefiency virus (BIV) and 
jembrana disease virus (JDV) (4, 18,22,33,39,49,53,69). 
Bovine lentiviruses are a group of lentivirus with different pathogenicities in 
infected cattle. Bovine lentivirus-infected cattle are found in many countries, 
including the USA, Indonesia, France, Australia, New Zealand, Costa Rica and 
Germany (45,47,53,64,70,79). At this time, there are two species of bovine 
lentivirus, bovine immunodeficiency virus (BIV) and jembrana disease virus (JDV). 
Bovine immunodeficiency virus {BIV) 
Bovine immunodeficiency virus is found worldwide and causes nonacute, 
chronic immune and central nervous system lesions. BIV is a mildly pathogenic 
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lentivirus and there are few reports of overt clinical disease caused by BIV. BIV 
was largely ignored until studies indicated that BIV was morphologically, 
serologically and genetically related to HIV, the agent of AIDS (39). Two strains of 
BIV have been isolated, R-29 and Florida strain. 
R29, the original bovine lentivirus, was isolated in 1969 from the leukocytes 
of a cow in Louisiana with persistent lymphocytosis, lymphadenopathy, lesions in 
the central system, progressive weakness and emaciation (79). Later studies 
examined the effects of BIV in experimentally infected calves. Clinical signs 
following BIV infection were transient and included pyrexia, neutropenia and 
lymphocytosis (29,63). After 3 months post inoculation ·(Pl), BIV infection was 
associated with an increase in the lymphocyte blastogenic response to the mitogen 
phytohaemagglutinin. In addition, neutrophil antibody dependent cell mediated 
cytotoxicity and neutrophil iodination were decreased (29). The levels of BIV 
replication in vivo were very low. During peak periods of viral replication in vivo, 
there were less than 0.03% of peripheral blood mononuclear cells expressing 
detectable levels of viral RNA by in situ hybridization (8). Though an early decline 
in Gag-specific antibody reactivity was observed in BIV infection, there was no 
evidence of increasing viral replication or progression to overt clinical disease (48). 
All infected animals were clinically normal through 27 months Pl. 
The Florida strain of BIV includes two isolates, FL 112 and FL491, which 
were obtained from a seropositive cattle herd in Florida in 1993 (76). In vitro, the 
Florida isolates showed differences in replication characteristics and syncytial 
appearance as compared to the original R-29. There was a longer incubation time 
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between passages and slower lysis of the infected cells. In vivo, FL 112-infected 
calves had greater increases in the number of mononuclear cells and more 
pronounced histopathological lesions than R29 infected cattle (76). However, 
FL491-infected calves were similar to R29-infected calves. In other lentivirus 
infections, in vitro characteristics are often correlated with virulence in vivo. In HIV, 
the more cytopathogenic lentiviral strains in culture are associated with greater in 
vivo virulence (16,46,56,57). Though there were some differences in pathogenicity 
among the different BIV isolates, in general, BIV was found to be a mildly 
pathogenic lentivirus and there have been no reports of acute and fatal disease 
caused by BIV in naturally or experimentally infected cattle. 
Jembrana disease virus (JDV) 
The other species of bovine lentivirus, jembrana disease virus (JDV) , shows 
dramatic differences in pathogenicity from BIV. JDV causes an acute, fatal disease 
in Bali cattle, Bos javanicus (74). The major clinical signs in JDV-infected animals 
are fever, lethargy, anorexia and enlargement of the superficial lymph nodes. Not 
all of these clinical changes occurred in all infected cattle. The major 
hematological changes were a leukopenia, lymphopenia, eosinopenia, a slight 
neutropenia, a mild thrombocytopenia, elevated blood urea concentrations and 
reduced total plasma protein. The clinical signs persisted for 5-12 days and most 
infected cattle recovered without recurrence of the disease. The mortality rate in 
the experimentally infected cattle was 17% (74). The complete nucleotide 
sequence of the JDV RNA genome was reported (12). The studies showed JDV 
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morphogenesis, protein structure, antigenic relationship and genome structure 
were similar with BIV's, and JDV was also classified as a bovine lentivirus (12). 
Even though BIV and JDV are both bovine lentivirus, the pathogenesis caused by 
the two bovine lentiviruses are very different. It is not known what factor(s) are 
responsible for these differences. One notable difference between JDV and BIV is 
the different levels of virus replication in vivo. Therefore, the factor(s) which control 
viral replication may contribute to viral pathogenesis. 
Lentivirus Gene Regulation 
Characteristics of lentiviruses 
Lentivirinae are one of the three subfamilies of retrovirus. The other two are 
oncovirinae and spumavirinae. Oncoviruses are named for their ability to cause 
neoplastic disease in the infected animals. Viruses originally isolated as tumor-
inducing agents, as well as related viruses, are traditionally placed into the 
subfamily oncovirinae. The oncovirinae includes five groups which are not closely 
related to one another. The five groups are the Avian Leukosis-Sarcoma Virus 
(ALSV) group, the Mammalian C-type virus group, the B-type virus group, the D-
type virus group, and the HTLV-BLV group. The spumaviruses are agents which 
cause vacuolation of cells in culture. The spumaviruses are not associated with 
any known disease and are by far the least well characterized of the retroviruses 
(19,24,30). Lentiviruses are a group of exogenous viruses with the most complex 
genome structure. 
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Lentivirus genome organization 
Retroviral genomes are diploid and composed of two identical positive 
sense RNAs that are non-covalently bound to each other. The 5' end of genome is 
modified by the cellular transcription machinery in the form of m7G5'ppp5'GmP· 
There is a poly(A) sequence in the 3' end which is added as a posttranscriptional 
modification to newly synthesized transcripts by the cellular mRNA processing 
machinery. The genomic RNAs, like cellular mRNAs, are modified 
posttranscriptionally by methylation on the 6 position of occasional adenosine 
residues. All retroviral genomes share organizational similarities in the special 
arrangement of the protein-encoding genes, gag-pol-env, which are flanked by the 
long terminal repeats (LTRs). The gag gene encodes a precursor polyprotein 
which is subsequently cleaved to several capsid proteins. There are three 
invariant ones: the matrix protein, the capsid protein, and the nucleic-acid-binding 
protein. The pol gene encodes the three proteins: the reverse transcriptase, 
protease and the integrase. The reverse transcriptase, as indicated by its name, 
functions in transcribing the RNA genome to double strand DNA. The integrase is 
needed in the integration of the viral DNA into cell DNA. The protease functions in 
the posttranslation process. The env gene encodes the two envelope 
glycoproteins. One is the surface protein which is responsible for recognition of 
cell-surface receptors. The other one is the transmembrane protein which anchors 
the SU to the virion envelope (19,24,30). Lentiviruses have a variable number of 
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accessory genes, such as Tat, rev, nef, vif, vpr, and vpu, which play an important 
role in viral gene regulation and in the viral life cycle (32,43). 
The life cycle of lentiviruses 
Lentiviruses attach to the host cell by interaction with a specific cell-surface 
receptor. For HIV, the CD4 cell-surface protein is the main receptor and was the 
first retrovirus receptor to be identified (22). HIV-1 also uses different co-
receptor(s), resulting in a distinctive host range for different virus strains. After 
binding of the SU protein to its receptor and co-receptor(s), the virus envelope and 
the cell membrane fuse to release the virion core into the cytoplasm. After the core 
penetrates into cytoplasm, the process of reverse transcription of the RNA genome 
into double-strand DNA occurs. During this process, the U3 and US regions 
duplicate to form the long terminal repeat (LTR}. The synthesized double-strand 
DNA translocates into the nucleus and integrates into the cell chromosome by 
integrase encoded by viral genome. At this phase, the virus is called a provirus. 
The efficient expression of the provirus starts in the L TR which provides signals 
recognized by cellular transcription machinery. The provirus is transcribed into 
viral mRNA and spliced RNAs are transported to the cytoplasm. The early gene 
expression produces two important regulatory proteins, Tat and Rev (21 ), which 
translocate to the nucleus to regulate viral gene expression. Tat functions to 
increase transcription initiation and elongation by binding a specific RNA structure; 
termed TAR, which is present on all nascent mRNAs (52,67). While Tat influences 
virus gene expression overall, Rev exerts a differential effect in the virus life cycle. 
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Rev protects mRNA from complete splicing (21,28,71 ). In the late stage, 
incompletely spliced mRNAs serve as templates for synthesis of the viral structural 
proteins, including gag, pol and env (21 ). Gag and Pol are translated from the 
same polycistronic mRNA by open-reading frame frameshifting. However, Env is 
translated from a single spliced mRNA. The virus genome replicates itself to many 
daughter genome RNAs as virus synthesizes its structural units. Then, the 
structural proteins and genomic RNA assemble into the virion and bud out from 
host cell. The L TR, the only promoter in the lentivirus genome, plays a critical role 
in the regulation of viral transcription and replication. The function of L TR is 
important to the virus life cycle. 
The Long Terminal Repeats 
The long terminal repeat (L TR) plays a very important role in a number of 
viral activities, including reverse transcription, integration, transcription, and 
replication. The L TR is organized into three regions, referred to U3, R and US 
(19,24,77). The U3 region provides signals recognized by cellular transcription 
factors. Some sequences act as enhancers to increase viral transcriptional 
efficiency (19,24,77). The TATA box is located in the U3 region, and functions to 
accurately initiate transcription (6,73). Transcription starts from the Rand US 
border. In the nascent RNA, the second structure of TAR is the critical binding site 
for Tat function (43,80). 
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Basal activity 
Basal activity is the activity of the LTR in the absence of Tat. In HIV, the U3 
region, containing many cellular transcription factor binding sites, is the main 
contributor to the basal activity. In the highly divergent U3 region, the TATA and 
CCAAT boxes, which are the consensus sequences suggested by the names, are 
strongly conserved and cannot be deleted, inverted, or moved elsewhere without 
greatly reducing viral gene expression (6,19,73). Besides the TATA and CCAAT 
boxes, the other cellular transcription factors, such as NF-kB and SP1 , act as 
enhancers to affect the overall expression of L TR. Enhancers are defined as 
control sequences or groups of control sequences, usually found upstream of the 
cap site, which increase the frequency of initiation of transcription but do not 
themselves specify or provide the sites for transcription. The SP1 and NF-kB are 
the two critical ones in HIV-1 LTR activity (13,68). SP1 , an important transcription 
factor, not only affects the basal level activity of the HIV-1 L TR but also interacts 
with the Tat protein and functions in transactivation (41,50,51 ). Deletion of all the 
three SP1 sites reduces the enhancer activity (50). NF-kB plays a pivotal role in 
stimulation of HIV transcription after T-cell activation, though it may not be 
absolutely required for viral growth. Moreover, NF-kB is the target of several signal 
transduction pathways involving both cellular and viral proteins (14,59,65). Point 
mutations in the NF-kB responsive elements decrease dramatically transcriptional 
activity (65) and may be associated with a longer period of viral latency in vivo (78). 
There are reports which suggest that deletion of some factor binding sites affects 
13 
not only the basal activity but also the transactivation of the L TR (10,31,35). 
Therefore, though basal activity in some lentiviruses is much lower than the 
transactivation, some factors which function in the basal activity also play a role in 
the viral transactivation. 
Transactivation 
All viral transcription is activated by some cellular factors which function at 
the U3 sequence in the proviral L TR. The host cell machinery is not sufficient for 
efficient viral gene expression and just provides a low, basal level of viral mRNA 
synthesis. In the presence of the virus encoded transactivator, Tat, the viral 
transcription level increases dramatically over the basal level of transcription. 
Although the exact function of Tat in transcription is not well understood, Tat is 
believed to play a role in two events. One is to increase transcription initiation 
(54,58,61,75). In this process, Tat possibly acts to facilitate assembly of the RNA 
pol II complex (58). The other one is to increase transcription elongation efficiency 
(20,52,54,58,61 ). The hypothesis that the Tat serves as an anti-terminator is 
derived from studies showing that Tat had little effect on the level of RNA 
polymerase density adjacent to the transcription initiation site, but dramatically 
increased the transcription rate of sequences distal from the HIV L TR (52). 
The HIV Tat protein is a 86 amino acid peptide encoded from two separate 
exons. The first exon, encoding the first 72 amino acids of HIV-1 Tat, contains 
functional regions of the protein. Tat protein can be separated into different 
domains according its function (Fig. 1 ). The N-terminal domain is the first 22 amino 
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acids with no reported function. Amino acids 22 to 37 contain a cys-rich domain. 
Any mutations in six of the seven Cys residues abolish Tat function. The next nine 
amino acids (amino acids 40 through 48) are called the core domain which is 
conserved in many lentiviruses. Amino acids 49 to 72 contain an arginine-rich 
(RKKRRQRRR) basic domain, which is responsible for RNA binding and nuclear 
localization (Fig.1). HIV-1 Tat loosely binds to the bulge region of TAR and cellular 
N-term Cys-rich Core Basic C-term 
Fig. 1. Organization of functional domains of HIV Tat-1 
factors which bind to the loop region in TAR stabilize Tat binding and possibly 
increase transcription levels by interaction with Tat. The precise TAR structure is 
very important to Tat function. Any deletion or nucleotide substitution in the bulge, 
loop or stem region which changes the hairpin structure decreases HIV 
transactivation levels dramatically (1-4). Results from numerous studies indicate 
that Tat is not only involved in the transcriptional elongation but also in initiation. 
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Fig. 2. Comparison of the proviral genome structures of BIV, JDV, and HIV. All 
identified or predicted open-reading frames (ORFs) of the three lentiviruses are 
shown. Besides the common LTR-gag-pol-env-LTR structure, they all have Tat, 
Rev and Vif regulatory ORFs. 
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The L TRs of Bovine Lentiviruses 
Bovine lentiviruses have a similar overall genome structure as HIV and other 
lentiviruses (Fig. 2). Flanking the gag-pol-env structural genes are the two L TRs. 
The BIV R29 L TR has been the only bovine lentivirus L TR studied to date. In the 
U3 region of the BIV L TR, there are some transcription factor binding sites which 
contribute to the viral basal activity. Transcription starts from the U3 and R border. 
In the nascent mRNA, the secondary hairpin structure TAR is critical for Tat 
transactivation. 
In the U3 region, many transcription factor binding sites (TFBS) were 
identified by computer analysis and their functions were studied by deletion and 
point mutations (Fig.3, Table 1) (10,31 ). In the Cf2th cells, CAT activity data 
indicate that NF-kB, GRE (glucocorticoid responsive element), CAAT, ATF, AP-4, 
and AP-1 sites are important in transcription. The importance of some factors 
differs in different cell types. For example, the AP-4 binding sequence was shown 
to be more important for L TR activation in BLAC-20 cells than in Cf2th or EREp 
cells. The first SP-1 site (-77) appears to have a negative effect in Cf2th cells, but 
not in BLAC-20 and EREp cells. The CAAT site is required for LTR function in all of 
the cell types tested (10,31). Therefore, LTR activity varies in different cell types as 
a result of the presence and/or absence of cellular factors that interact with TFBS in 
the BIV LTR. 
Activity 
U3 R U5 Basal Trans- Fold 
pBIVLTR 0 e 00 ~ 0.23 10.60 46.09 
-384 z G> ~ ~~ ~ ~ ~~ ~ ~ ~ TATA TAR 204 "fl lJ 
"" 
m i ml> ~ m o~ .................. 
tlJ JJ 
m 
p3D+140 0.33 15.57 47.18 
p3D+78 0.20 11.33 56.65 
p3D+54 0.50 17.67 35.34 
p3D+26 0.17 0.30 1.76 
p3D+19 0.27 0.40 1.48 
p3D+12 0.23 0.33 1.43 
p3D-23 0.17 0.27 1.59 
p5D-74 0.23 6.37 27.69 
p5D-115 0.27 12.37 45.81 
p5D-207 0.30 17.63 58.77 
p5D-319 0.27 13.97 51 .74 
Fig. 3. Summary of the previous studies of BIV L TR activity (10,31 ). The sequence of the full-length L TR is shown 
on the top as a solid line. The location of the U3, R and US regions are indicated above the line of the full-length 
L TR. The TAR sequence is bolded. The identified transcription factor binding sites are indicated under the line of 
the full-length L TR. The plasmids with truncated L TRs are named by the 5' or 3' terminal deletion and numbered 
with respect to the transcription start site(+ 1 ). The BIV L TR activity is measured by CAT activity. Results are given as 
percentages of [14C]chloramphenicolconvertd to its acetylated form and are means of three transfections. Fold 
transactivation is determined by the ratio of transactivation to the basal activity. 
...... 
....... 
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Besides the activities of these cellular factors in L TR function, Tat-mediated 
transactivation is important for bovine lentivirus L TR activity. Similar to HIV-1, the 
binding site of BIV Tat is in the bulge region of the BIV TAR (15). Though BIV Tat 
has a different way to bind its target site, the secondary hairpin structure of TAR is 
also important for BIV Tat function. Deletion or point mutations of the TAR sequence 
showed that changes in the bulge or stem region would decrease Tat-mediate 
activity dramatically. However, if the deletion or mutation occurred in the loop 
region, there was little effect on Tat function (10,15,31). These data indicated that 
the BIV TaVTAR interactions differed from HIV TaVTAR. Further analysis showed 
that BIV Tat binds its TAR tightly, and there is no cellular loop binding protein 
required to stabilize TaVTAR interaction (15). The BIV Tat mediated transactivation 
is not as high as HIV Tat mediated transactivation (15). There is still a lot of work 
needed to elucidate the role of cellular protein(s) and TaVTAR interaction in bovine 
lentivirus transactivation. 
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Table 1. Functional sequences in BIV L TR1 
Transcription Factor Location Effect of deletion on L TR activity2 
Binding Sites Basal Transactivation 
NF-kB -348 to -299 40.7 29.9 
GRE -252 to -247 17.0 22.8 
Ap-4 -183 to -176 69.9 50.5 
Ap-3/RCE -174 to -168 166.4 123.1 
Ap-1 -142 to -135 39.9 34.8 
CAAT/ATF -105 to -94 29.8 13.9 
SP-1 -66 to -58 313.3 91.0 
1/2 TAR +32 to +69 155.8 155.2 
R-US +1 to +204 216.0 4.0 
us +109 to +204 616.6 598.9 
1. Summary from Ref. 31 
2. Compared to the wild type of L TR activity which is set to 100 in both basal and 
transactivation 
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CHAPTER 3. FUNCTIONAL CHARACTERIZATION OF 
BOVINE LENTIVIRUS L TRs 
A paper to be submitted the Journal of Virology 
Jun Yang and Susan Carpenter 
Abstract 
Lentiviruses, a subfamily of retroviruses, are a group of exogenous, 
nononcogenic viruses which cause chronic and variable clinical disease. The 
three bovine lentiviruses that have been characterized so far are the R29 and 
FL 112 bovine immunodeficiency viruses (BIV), and the jembrana disease virus 
(JDV). These viruses have different pathogenicities and different levels of 
replication in their hosts. The long terminal repeat (LTR), including U3, Rand US, 
is the only promoter of lentiviruses and it plays a critical role in the basal and Tat 
mediated transcription of viral RNA. Comparison of the L TR sequences of R29, 
FL 112 and JDV shows that the differences between R29 and FL 112 mainly occur 
in the U3 region. The difference between JDV and BIV is found throughout the 
whole L TR. Because of the nucleotide substitutes within the R region, the predicted 
JDV secondary structure of the transactivation response region (TAR) is different 
from that of BIV. To determine if the LTR sequence heterogeneity among R29, 
FL 112 and JDV differentially regulates the basal and/or Tat mediated transcription, 
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the three L TRs were inserted into a CAT reporter plasmid and transfected into Cf2th 
and 293 cells with or without a Tat expression plasmid. The CAT assay results 
show that, in the presence of Tat, the activity of FL 112 was much higher than R29-
4093 or JDV L TR constructs in both cell types. Interestingly, the activity of the JDV 
LTR construct was less than FL 112 and R-29. To map the region important for the 
lower JDV L TR activity, chimeric L TRs were constructed by replacing either U3 or 
RUS of BIV with that of JDV. Results showed that chimeric L TRs had dramatically 
decreased activity in both cell types. These data suggest that the L TR contributes 
to differences in BIV replication in vivo, but that other factors may be more important 
in control of JDV replication. 
Introduction 
Bovine lentiviruses are a group of lentiviruses that cause variable 
pathogenicities in infected cattle (36,38,39,79). There are two species of bovine 
lentiviruses identified at this time, bovine immunodeficiency virus (BIV) and 
jembrana disease virus (JDV) (36,38,39,53). BIV, a species of bovine lentivirus 
with worldwide distribution, contains two known strains, R29 and Florida strain. 
Most characterized isolates of BIV are related to R29 (39,76). Compared to R29, 
the Florida strain, in vitro, has longer incubation time between passages and 
slower lysis of infected cells. In vivo, FL 112-infected cattle show increases in the 
number of mononuclear cells and more pronounced histopathological lesions 
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(39,76). Despite these differences between R29 and FL 112, BIV is a mildly 
pathogenic bovine lentivirus and there are no reports of overt clinical disease 
caused by BIV in naturally or experimentally infected cattle. JDV, the other species 
of bovine lentivirus, is found in some species of cattle in Indonesia, especially in 
Bali cattle, Bos javanicus (26,66). The major clinical signs of JDV-infected cattle 
are fever, lethargy, anorexia and enlargement of the superficial lymph nodes. The 
mortality rate of experimentally infected cattle is reported to be 17%. After 5 to 12 
days of infection, viral titre can reach 108 units per ml (26). JDV replicates very fast 
and causes acute fatal disease in infected animals. Therefore, the three bovine 
lentiviruses, R29, Florida and JDV, cause quite different clinical disease courses 
and different levels of viral replication in infected cattle. 
In lentiviruses, the long terminal repeat (L TR) is the only promoter and plays 
an important role in viral gene regulation and pathogenesis (21,37,44). In addition 
to enhancer elements in the U3 region, transcription increases dramatically in the 
presence of the viral transactivator, Tat (3,4, 10, 11,27,60). The interaction between 
Tat and its binding site, termed transactivation response region (TAR) is specific, 
and the precise secondary TAR structure is critical to Tat function (5,7, 15, 17). In 
HIV, cellular loop-binding factor(s) stabilize the Tat!f AR binding and play a role in 
tat-mediated transactivation (25,42,81 ). Though the deletion and point mutation 
analysis indicate no cellular loop binding factors are required in BIV transcription 
(10), additional cellular factors are likely to be important for Tat function and L TR 
activity. Therefore, the contributors to optimal activity of the L TR are the L TR 
sequence, Tat, and cellular factors. Functional characterization of the L TRs of the 
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three bovine lentiviruses showing obviously different pathogenicities may 
demonstrate the contribution of the L TR in virus replication in vivo and 
pathogenicity. 
Materials and Methods 
Cells and virus 
Two cell lines were used to conduct transient transfection assays for the 
different L TR and chimeric LTR constructs. The Cf2th (ATCC CRL-1430) cell line is 
permissive for many lentiviruses, including BIV, and has been used previously in 
studies of BIV LTR function (31,63). 293 cells (ATCC CRL-1573) are a transformed 
primary human embryonic kidney cell line and continuously produce adenovirus 
E1A protein which can increase HIV LTR activity (55). 
Fetal bovine lung cells (FBL) were used to cultivate FL 112 and R29 bovine 
lentiviruses for isolation of proviral DNA. All cells were propagated in Dulbecco's 
minimum essential medium (DMEM) supplemented with antibiotics and 10% fetal 
calf serum. 
BIV L TR sequence analysis 
Cell free virus stocks of R29 and FL 112 virus were used to infect low 
passage fetal bovine lung (FBL) cells. R29-4093 isolate was used as R29. After 4-
5 days when syncytia were present, the infected cells were collected and total DNA 
was extracted using SDS-proteinase K (1,8). 
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The FL 112 L TR was PCR amplified with 88260 and 88963C' primers (Table 
2) from the FL 112 proviral DNA, and the PCR product was cloned into the TA vector 
(Strategene). The PCR amplification consisted of a total of 30 cycles: 94°C 2 min; 
30 cycles of 94°C 1 min, 50°C 1 min and 72°C 2 mins; 5 mins extension at 72°C. 
Clones were screened by restriction enzyme analysis and one plasmid was 
sequenced as the FL 112 L TR sequence. The R29 L TR sequence was derived in 
the same way as that of FL 112 L TR. The R29 L TR was amplified by PCR from R29 
proviral DNA with 88375 and 88963C' primers and the PCR product was cloned 
into the TA vector. A correct clone was verified by restriction enzyme analysis and 
was sequenced. 
Vector construction 
Tat expression plasmids were constructed by insertion of the 81V Tat exon I 
or JDV Tat exon I PCR-amplified fragments into a pCR3.1 expression vector. The 
R29 proviral DNA was as the template for 81V Tat exon I. The oligonucleotides 
85602 and 85965C' were used as primers for PCR amplification of the 81V Tat 
exon I. The PCR amplification conditions were the same as described above. A 
pUC19 plasmid containing a partial JDV cDNA sequence, including JDV Tat 
exon 1 , was supplied by Dr. Charles Wood of the University of Nebraska. The 
primers J4978 and J5316C' were used for PCR amplification of the JDV Tat exon I. 
The same amplification conditions described above were used. The 363 bp 81V 
Tat and 338 bp JDV Tat exon I PCR fragments were ligated separately into pCR3.1 
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expression vector and transformed into E.coli. The positive clones were identified 
and verified by sequence analysis. 
To construct the L TR-CAT reporter plasmids, the L TRs of R29, FL 112 and 
JDV were amplified by PCR using primers specific to each L TR sequence of the 
three isolates. They are, respectively, 88375 and 88963C', 86' and 88963C', and 
J7381 and J 159C'. Amplified products were cloned into pCR2.1. Clones with the 
correct insert and orientation were identified by restriction enzyme analysis and 
verified by sequencing. A Hindlll- Xbal L TR fragment was excised, purified and 
inserted into the Hindlll & Xbal sites in pCAT basic plasmid (Promega) and 
sequenced. 
The PLP ( PCR .Ligation PCR ) technique was used to construct the chimeric 
LTR CAT reporter vectors (Fig.4). The U3 fragment of FL 112, RU5 fragment of JDV, 
and U3 of JDV and RU5 of R29-4093 were amplified with Vent polymerase, 
creating blunt ends in the amplifi~d products. The primers were 88375 and 
8384C' for the R29-4093 U3 region; 86' and 8384C' for the FL 112 U3 region; and 
J4 and J159C' for the JDV RU5 region; J7381 and J7604C' for the JDV U3 region; 
and 8388 and 88963C' for the R29-4093 RU5 region. The U3 and RU5 fragments 
were purified and the RU5 fragments were phosphorylated by T 4 kinase, then 
ligated with a high concentration of T4 ligase (50 units per reaction). The chimeric 
U3 - RU5 was amplified with the 5' primer of U3 and the 3' primer of RU5 by Taq 
polymerase. Amplified products were ligated to the PCR vector and subcloned into 
pCAT basic plasmid as described above. All constructs were verified by sequence 
analysis. Fig.5 summarizes the CAT constructs used in this study. 
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Table 2. Summary of the primers used in this study 
name sequence NT sequence 
location* 
88963C' 5'-CTGTTGGGTGTTCTTCACCG-3' 187-206 
88260 5'-GGATCTCCTGACCCCTCAAC-3' 7874-7893 
88375 5'-TGTGGGGCAGGGTGGGACCT-3' 7988-8007 
85602 5'-GA TTGTGGCAA T ATGCCCGGA-3' 5216-5236 
85965C' 5'-GGACAGCA TTCCTGCCAGG-3' 5561-5579 
J4978 5'-AACCAAGGAGGGGATCAACC-3' 4978-4997 
J5316C' 5'-CCGTGATCTTCCAGGGTCCA-3' 5317-5336 
86' 5'-GGGAAGCTT AAAAGGGTGGACTGTGG-3' 7973-7992 
J7381 5'-GGGAAGCTTGGTGGACTGTGGGGAGAA-3' 7382-7398 
J159C' 5'-GCTTCTAGA TTGGGTGGTTCTTGTTCGG-3' 141-159 
8384C' 5'-CCCCGT ACAGAGTGAAGATAGG-3' 8356-8371 
J4 5'-CTCTGGATAGCTGACAGCTCCGAGCCCCCAG-3' 5-35 
J7604C' 5'-TGAAGTTGCAGAA TGCTCATGTGC-3' 7604-7624 
8388 5'-GCTCGTGT AGCTCA TT AGC-3' 5-23 
*Nucleotide sequence numbers are based on the BIV127 (Genebank M32690) for 
BIV primers and on JDV (Genebank U21603) for JDV primers. 
Cell transfection and CAT assays 
Cf2th or 293 cells were seeded in triplicate at 3X105 cells/well in 6-well 
tissue culture dishes. The following day, cells were transfected with L TR CAT 
constructs and CAT activity was quantified using methods similar to those 
previously described (10). Briefly, L TR-CAT construct were transfected with or 
without BIV/JDV Tat plasmid. All reactions contransfected with 0.Sug beta-
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PCR #1 (Vent polymerase) 
Ul...,_ 
LTR2 
+ 
...... n2 
PCR #2 (Taq polymerase) 
U2...,_ 
U2...,_ t ...... n2 
I RU5 
...... n2 
Fig. 4. PLP to construct chimeric L TRs. The chimeric L TR contains the U3 region 
of the LTR1 and the RU5 region of the LTR2. The U1, 01 and U2, 02 are pairs of 
primers for PCR amplification of the U3 of L TR1 and the RU5 of L TR2 by Vent 
polymerase. The purified U3 of LTR1 and the RU5 of LTR2 fragments were 
phosphorylated and ligated together. Then the chimeric L TR was amplified by Taq 
polymerase with U1 and 02 primers. 
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Fig. 5. Summary of the L TR reporter constructs. The three bovine lentivirus L TRs 
and the chimeric LTRs were inserted upsteam of the CAT (chloramphenicol acetyl 
transferase) reporter gene in the pCAT basic vector. The LTRs were transfected 
and CAT expression was measured using procedures previously described (10). 
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galactosidase reporter plasmid pCH110 for measuring transfection efficiency and 
pUC19 DNA was added to normalize the total amount DNA in each well. Cells 
were transfected using calcium phosphate co-precipitation and the glycerol shock 
was performed 3 hours later for Cf2th cells. At two days post-transfection, cells 
were harvested, washed, resuspended in Tris buffer and then lysed three times by 
freeze-thawing in a dry ice ethanol bath. 50 ul lysate was assayed for beta-
galactosidase analysis and results were used to measure the transfection 
efficiency and normalize the amount lysates used for CAT assays. Reaction 
volumes for CAT assays were equalized with 0.25M Tris, pH7.5, to a final volume 
92 ul and incubated at 37C with 5 ul 20 mM acetyl coenzyme A and 3 ul of 50 
mCi/mmol 14C-chloramphenicol. Unacetylated and acetylated forms were 
separated by thin-layer chromatography and quantified using a Molecular 
Dynamics phosphoimager. The L TR plasmid with the highest CAT activity was 
used to normalize each experiment, and all experiments were repeated 2-4 times. 
Results 
L TR nucleotide sequence comparison 
To examine the L TR variability among the three lentiviruses, the LTRs of BIV 
R29 and FL 112 were sequenced and compared to the published JDV L TR 
sequence (Fig. 6). Differences in L TR sequence between FL 112 and R29 were 
found primarily in the U3 region. Though there was a 16 nucleotide deletion and 
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many nucleotide substitutions found in the FL 112 U3 region, the identified TFBSs 
were generally conserved between R29 and FL 112. In the R-U5 region, there were 
only two nucleotide substitutions. One was an A to C change at + 18 in the loop 
region of TAR. The other was a C to T change at +34 outside of TAR. From 
previous data, these changes are not expected to alter the TAR secondary structure 
or the activity of the L TR (8). 
The differences in L TR sequence between JDV and R-29 were more striking 
(Fig. 6). The JDV L TR is 397 bp long, which is 192 bp shorter than that of R29. 
This was primarily due to a 157 nt long deletion in the U3 region. There were many 
nucleotide substitutions, and except for the NF-kB site, the enhancer elements 
were poorly conserved between the JDV and R29 L TRs. From the transcription 
factor database, the only Sp-1 site found was farther upstream of TATA box (74nt) 
than in R29 (19nt). Other transcriptional motifs, including the CAAT sequence, 
were not found in the JDV U3 region. Because of many nucleotide substitutions in 
the R region, the predicted JDV TAR secondary structure was different from that of 
BIV. Since the TAR structure is critical for lentivirus transactivation, this suggested 
that JDV L TR activity may be significantly different from BIV L TRs. 
The result of the sequence comparison suggested that L TR sequence 
variation contributes to the different levels of viral replication and pathogenesis. 
The L TR activity and the importance of different L TR regions were tested in the in 
vitro transfection studies using different LTR-CAT, or chimeric LTR-CAT constructs. 
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* * * * * * NF-kB * * * *-313 
TAAACTTAAAAGGGTGGACTGTGGGGCAGGGTGGGACCTCAGGACAACAGCAG---- --CCC-ATATGTGAATTGGACTGGATCCAGGGA 
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Fig. 6. Sequence comparison of R29, FL 112 and JDV L TRs. The transcription factor binding sites are shadowed in 
boxes and the names are above the boxes. The U3, R and U5 regions are separated by vertical lines. The 
transcription start site is marked by the arrow. Dots indicate identity with R29, dashes indicate deletions. The TAR 
sequence is boxed. The numbering is with respect to the transcription start site (+1). 
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Comparison of L TR activity in cells permissive for BIV replication 
To test the function of the three bovine lentivirus L TRs in activating 
downstream gene expression, the three bovine lentivirus L TRs were inserted into a 
CAT reporter plasmid. The activities of L TRs were assayed by quantifying CAT 
expression in transient transfection assays. In the Cf2th cells, all L TRs had low, but 
detectable levels of basal activity (Fig. 8). The basal activity in BIV R29 was 3-5 
fold higher than that of FL 112 and JDV. In the presence of Tat, all LTRs were more 
active, however, the range of transactivation differed from 3 to 50 fold over the 
basal activity. FL 112 L TR was most active and had the highest fold of 
transactivation. The JDV LTR was least active and had lowest fold transactivation. 
R29 isolates were in intermediate in both transactivation and fold transactivation. 
Due to the low level of FL 112 basal activity, the difference in fold of transactivation 
between R29 and FL 112 was much higher than the difference in the overall level of 
CAT activity. For example, the activity of FL 112 L TR was just about 3 fold higher 
than R29-4093 in the presence of BIV Tat. However, compared to the fold 
transactivation, FL 112 was 9 fold higher than R29 (Fig. 8). 
The effect of cell types on L TR activity 
Host cell factors are required for L TR activity. BIV is reported to have a 
broad host range and it can be cultured in many cell types. However, JDV has 
never been cultured in vitro. It is possible that BIV L TRs have higher activity than 
JDV L TR in Cf2th cells because Cf2th cells contain factors which are permissive for 
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BIV replication, but not for JDV replication. Due to the low activity of the JDV L TR in 
Cf2th cells, 293 cells were used to test L TR function. 293 cells are a good choice 
because the transfection efficiency is high in 293 cells and these cells also have 
high levels of transcription factors, such as the E1A protein, which increase activity 
of the HIV LTR (55) . 
Results observed in the 293 cells were similar to that in Cf2th cells. FL 112 
showed the highest activity and fold transactivation. JDV L TR had the lowest level 
of activity in the absence or presence of Tat (Fig. 9). Therefore, the 293 cells could 
not supply the cellular co-factors necessary for JDV L TR activity. 
Compared to the data from Cf2th cells, the basal activity of FL 112 in 293 
cells was similar or even a little bit higher than R29 L TR. More striking, in 293 cells, 
the difference in activity between FL 112 and R29 was greater than that seen in 
Cf2th. In Cf2th cells, the FL 112 L TR was about 3 fold higher than R29 L TR in the 
presence of BIV Tat; however, in 293 cells, the FL 112 L TR was about 12 fold higher 
than the R29 L TR (Fig. 9). This suggests that the FL 112 is more active in 293 cells, 
possibly due to the presence of cofactors which interact preferentially with the 
FL 112 L TR, and not the R29 L TR. 
Functional comparison of BIV and JDV Tat 
A possible reason to account for the low activity of JDV L TR is the 
differences in the predicted TAR structure of JDV and BIV. The differences in TAR 
secondary structure could affect Tat function dramatically due to the critical role of 
TAR in Tat activity. To test this possibility, JDV Tat was used in the LTR 
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transactivation. Unexpectedly, JDV Tat did not transactivate JDV LTR to a high 
level (Fig. 8,9). So, the heterologous interaction between BIV Tat and JDV TAR 
was not the main reason for the low level of JDV LTR activity. JDV Tat could 
transactivate both BIV L TRs, but the transactivation mediated by JDV Tat was about 
two fold lower than that by BIV Tat in all L TRs in Cf2th cells and about three fold 
lower than BIV Tat in 293 cells (Table 3). The results indicated that JDV Tat did 
transactivate BIV LTRs. Also the BIV L TR could be transactivated by the 
heterologous Tat, although not as efficiently as with the homologous Tat. 
The activity of chimeric L TRs 
To test which part o LTR, the U3 or the RU5 region, contributes to the low 
level of JDV L TR activity, the chimeric L TRs were made by replacing JDV U3 or 
RU5 region with FL 112 U3 or RU5 region. The function of the chimeric L TRs was 
examined as described for the wild type L TRs. Comparing the CAT activity of J/FL 
standing for (JDV U3 - FL 112 RU5 chimeric LTR), FUJ and FL 112 LTRs, the FL 112 
L TR was much higher than the two chimeras (Fig. 10, 11 ). Both the basal and 
transactivation of J/FL were too low to be distinguished from the background in 
both cell types. The FUJ chimera could be activated by BIV Tat or JDV Tat, though 
the activity level was low. In the presence of BIV Tat, the transactivation of FL 112 
L TR was about 12 fold higher than Fl/J chimera in Cf2th cells, and about 23 fold 
greater than FUJ in 293 cells (Fig. 10, 11 ). Therefore, replacement of either U3 or 
RU5 of FL 112 L TR dramatically decreased L TR activity, indicating both the U3 and 
RU5 regions contribute to the low level of JDV L TR activity. 
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Table 3. Activity of LTRs in Cf2th and 293 cells 
LTRs Cell lines Basal Activity Transactivation 
BIVTat JDV Tat 
4093 Cf 2th 1.36±0.22 7.31±1.06 4.36±0.45 
293 0.55±0.21 2.84±1.60 1.77±0.02 
342 Cf 2th 1.28±0.34 15.47±1.95 5.52±0.80 
293 0.48±0.13 3.93±1.03 1.20±0.08 
FL112 Cf 2th 0.41±0.06 21.07±2.32 9.74±2.08 
293 0.84±0.51 30.00±1.38 8.43±1.10 
JDV Cf2th 0.24±0.12 0.75±0.14 0.39±0.10 
293 0.04±0.01 0.41±0.20 0.02±0.00 
Discussion 
The three natural bovine lentivirus, R29, FL 112, and JDV, are associated 
with different pathogenicities and different levels of viral replication in vivo. The L TR 
activity of the three lentiviruses were examined by inserting wild type L TRs into a 
CAT reporter plasmid. The L TR activity of FL 112 and R29 paralleled the 
differences of in vivo pathogenicity. In both cell lines, Cf2th and 293, FL 112 LTR 
showed higher transactivation than R29 L TRs, which reflected the increased 
pathogenicity of FL 112 in experimentally infected calves. Therefore, in BIV, the 
activity of L TR correlated with the level of viral replication and in vivo pathogenicity. 
However, the activity of JDV L TR was very low in both cell 
36 
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~BIVTat 
FL 112 - -i(50.17) 
~JDVTat 
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- (1.63) 
0 10 20 30 40 
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Fig. 8. Activity of L TRs in Cf2th cells. Cf2th cells in each well were transfected with 
0.2 ug R29, FL 112 and JDV L TR-CAT constructs, 0.5 ug ±..BIV Tat or± JDV Tat 
expression plasmid and 0.5 ug pCH110 DNA. % Acetylation is the ratio of the 
amount of the acetyled chloramphenicol to the total of chloramphenicol (acetyled 
and unacetyled). The data represent the mean of nine independent transfections ± 
SEM (standard error mean). The numbers in parentheses are the fold of 
transactivation, calculated as the ratio of the activity in the presence of Tat to the 
activity in the absence of Tat. 
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Fig. 9. Activity of LTRs in 293 cells. 293 cells were transfected with 0.1 ug R29, 
FL 112 and JDV L TR-CAT constructs, 0.5 ug ±...BIV Tat or± JDV Tat expression 
plasmid and 0.5 ug pCH110. % Acetylation is the ratio of the amount of the 
acetyled chloramphenicol to the total of chloramphenicol (acetyled and 
unacetyled). The data represent the mean of nine independent transfections + 
SEM (standard error mean). The numbers in parentheses are the fold of 
transactivation, calculated as the ratio of the activity in the presence of Tat to the 
activity in the absence of Tat. 
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Fig. 10. Activity of chimeric L TRs in Cf2th cells. Cf2th cells in each well' were 
transfected with 0.5 ug FL 112 LTR-CAT and FL 112 U3-JDV RU5 (FUJ) and JDV 
U3-FL RU5 (J/FL) chimeric LTR-CAT constructs, 0.5 ug ±.BIV Tat or± JDV Tat 
expression plasmid and 0.5 ug pCH110. % Acetylation is the ratio of the amount of 
the acetyled chloramphenicol to the total of chloramphenicol (acetyled and 
unacetyled). The data represent the mean of nine independent transfections ± 
SEM (standard error mean). The numbers in parentheses are the fold of 
transactivation, calculated as the ratio of the activity in the presence of Tat to the 
activity in the absence of Tat. 
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Fig. 11 . Activity of chimeric L TR in 293 cells. 293 cells in each well were 
transfected with 0.5 ug FL 112 L TR-CAT and FL 112 U3-JDV RU5 (FUJ) and JDV 
U3-FL RU5 (J/FL) chimeric L TR-CAT constructs, 0.5 ug ±..BIV Tat or± JDV Tat 
expression plasmid and 0.5 ug pCH110. % Acetylation is the ratio of the amount of 
the acetyled chloramphenicol to the total of chloramphenicol (acetyled and 
unacetyled). The data represent the mean of three independent transfections ± 
SEM (standard error mean). The numbers in parentheses are the fold of 
transactivation, calculated as the ratio of the activity in the presence of Tat to the 
activity in the absence of Tat. 
40 
types, and did not correlate with the high level of replication in vivo and the acute 
fatal disease course. 
To elucidate the reason for the low level of JDV LTR activity, we tested 
different transactivators (BIV Tat and JDV Tat), different cell types (Cf2th and 293 
cells) and U3 or RU5 substituted chimeric L TRs. The consistently low JDV L TR 
activity in the presence of JDV Tat indicated that the interaction between Tat and 
TAR was not the critical reason for the low JDV L TR activity in this study. The low 
JDV L TR activity in 293 and Cf2th cells suggested that both cell types may tack the 
required cellular factors for JDV L TR activity. The previous JDV infection studies 
showed that JDV only caused a severe disease in Bali cattle, not in other infected 
cattle species (71 ). Therefore, specific host factors may be present in Bali cattle 
which are required for JDV clinical disease. These factors may also play a critical 
role in L TR activity. This may account for the low JDV L TR activity in Cf2th (canine 
thymus cell) and 293 (human kidney cells). 
The chimeric L TRs were used to elucidate the critical sites for low JDV L TR 
activity. Substitution of the JDV U3 for FL 112 U3 eliminated activity. This suggests 
that Cf2th and 293 cells lack some absolutely required factors functioning in the 
JDV U3 region. These required cellular factors may be specific to host range or 
cell tropism. In EIAV, the U3 region plays an important role in virus cell tropism for 
EIAV (63). The low but detectable level of FUJ chimera suggested that the factors 
functioning in the RU5 region were important for the JDV L TR transactivation, 
though were not absolutely required. Therefore, both the JDV U3 and the JDV RU5 
region accounted for the specific JDV L TR function in which cellular factors played 
41 
an important role. The results of JDV L TR sequence analysis showed that the 
CAAT box, found in most eukaryotic genes, was missing in the JDV L TR. 
Therefore, the JDV L TR itself may be responsible for the low level of activity. 
Furthermore, the JDV L TR clone came from the cDNA sequence, and may not 
represent the in vivo active L TR. Therefore, the reasons for the low level of JDV 
L TR activity are still unknown. 
The comparison of the activity between R29 and FL 112 in Cf2th and 293 
cells also support the importance of cellular factors in L TR activity. The difference 
in the activity between R29 and FL 112 was greater in 293 cells than in Cf2th cells. 
This suggests that 293 cells support FL 112 L TR activity better than Cf2th cells. 
Therefore, the interaction between host cellular factors and the viral genome is 
important for L TR activity and forviral pathogenicity. 
The activity of JDV Tat was lower than BIV Tat in both cell lines and with all 
L TRs except the FUJ chimeric L TR. Though the amino acid sequence comparison 
showed that JDV Tat had the same domains, (N-terminal, Cys-rich, Core, Basic and 
C-terminal) as BIV Tat, more studies are needed to determine if the low activity is 
due to the low activity of JDV Tat itself, or to the missing co-factors which were 
specific to JDV Tat not BIV Tat. 
The results of this study showed that the function of BIV L TR paralleled the in 
vivo viral levels of replication and pathogenicity. Though the results of JDV L TR did 
not correlate with the high viral replication and severe pathogenicity in vivo, this 
study highlights the need for more JDV research, especially the elucidation of the 
mechanism of JDV L TR function. 
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CHAPTER 4. GENERAL CONCLUSIONS 
Bovine lentiviruses are a group of lentiviruses with different pathogenicities 
in cattle. The viral replication level is associated with its pathogenesis. The long 
terminal repeat (L TR), which flanks the lentivirus structural genes, is the only 
promoter in the lentivirus genome. Therefore, the function of the L TR is critical to 
viral replication and viral pathogenesis. This study took advantage of the three 
natural bovine lentiviruses with different pathogenicities to elucidate the role of the 
LTR in viral pathogenicity. 
The sequence comparison of the three bovine lentivirus L TRs showed that 
the differences between R29 and FL 112 L TR were found in the U3 region and did 
not alter TAR structure. The differences in L TR sequence contributed to different 
L TR activities. The results of this study showed that the activity of FL 112 L TR was 
higher than R29 in both Cf2th and 293 cell lines. Therefore, in BIV, the higher L TR 
activity of FL 112 correlated with the more pathogenicity in vivo. 
However, the low activity of JDV L TR in both cell types did not parallel the 
severe disease course in vivo. Though the reasons for the low JDV L TR activity are 
still unknown, this study explored some possibilities and raised some interesting 
ideas. In our system, Cf2th and 293 cells, JDV Tat could activate the three bovine 
lentivirus LTRs though the activity was lower than BIV Tat. This result suggested 
that the heterologous interaction between BIV Tat and JDV TAR was not the main 
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reason for the low activity of the JDV L TR. The absence of required cellular factors 
was the most likely reason for the low activity of JDV L TR. This is supported by 
previous data indicating that among different JDV-infected cattle species, only Bali 
cattle developed severe disease. The results of the activity of chimeric L TRs 
indicated that the cellular factors functioning in the JDV U3 region were absolutely 
required for the JDV L TR activity and that the RU5 region also played important 
role. 
Sequence analysis indicated that JDV L TR did not contain a CAAT box 
which is present in most eukaryote genes. So the JDV L TR itself may also 
contribute to the low activity. Furthermore, the sequence and clone of the JDV LTR 
came from a JDV cDNA, and it may not represent the JDV L TRs in vivo. Therefore, 
the mechanism of the function of JDV L TR is still unknown. 
This study explored the contribution of the activity of the L TR to viral 
pathogenicity in the three bovine lentiviruses which showed different L TR 
sequences and different pathogenicities in vivo. This initial study of the JDV L TR 
provided more interesting ideas which would benefit later functional studies of the 
JDV L TR. Therefore, the results of the study will help to elucidate the mechanism of 
L TR function and the relationship between L TR function and viral pathogenesis, 
and may be practical benefit to cattle research. 
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